Characterization of human cytochrome P450 enzymes catalyzing domperidone N‐dealkylation and hydroxylation in vitro
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Aims: To confirm the identity of the major metabolites of domperidone and to characterize the cytochrome P450s (CYPs) involved in their formation. Methods: Human liver microsomes (HLMs) were used to characterize the kinetics of domperidone metabolism and liquid chromatography‐mass spectrometry to identify the products. Isoform‐specific chemical inhibitors, correlation analysis and expressed human CYP genes were used to identify the CYPs involved in domperidone oxidation. Results: In HLMs, domperidone underwent hydroxylation to form 5‐hydroxydomperidone (MIII) and N‐dealkylation to form 2,3‐dihydro‐2‐oxo‐1H‐benzimidazole‐1‐propionic acid (MI) and 5‐chloro‐4‐piperidinyl‐1,3‐dihydro‐benzimidazol‐2‐one (MII). The formation of all three metabolites (n = 4 HLMs) followed apparent Michaelis‐Menten kinetics. The mean Km values for MI, MII and MIII formation were 12.4, 11.9, and 12.6 µm, respectively. In a panel of HLMs (n = 10), the rate of domperidone (5 µm and 50 µm) metabolism correlated with the activity of CYP3A (r > 0.94; P < 0.0001). Only ketoconazole (1 µm) (by 87%) and troleandomycin (50 µm) (by 64%) inhibited domperidone (5 µm) metabolism in HLMs. Domperidone (5 and 50 µm) hydroxylation and N‐dealkylation was catalyzed by expressed CYP3A4 at a higher rate than the other CYPs. CYP1A2, 2B6, 2C8 and 2D6 also hydroxylated domperidone Conclusions: CYP3A‐catalyzed N‐dealkylation and aromatic hydroxylation are the major routes for domperidone metabolism. The drug would be expected to demonstrate highly variable bioavailability due to hepatic, and possibly intestinal first‐pass metabolism after oral administration. Increased risk of adverse effects might be anticipated during concomitant administration with CYP3A inhibitors, as well as decreased efficacy with inducers of this enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
Cited by
Mishra, H., Polak, S., Jamei, M., & Rostami‐Hodjegan, A. (2014) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2014.26 · Cited by 24
Metadata
- Authors
- Ward, B. A., Morocho, A., Kandil, A., Galinsky, R. E., Flockhart, D. A., & Desta, Z.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2004-06-21
- Volume
- 58
- Issue
- 3
- Pages
- 277-287
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2049902803
- Cited by
- 51
- References
- 1
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of human cytochrome P450 enzymes catalyzing domperidone N‐dealkylation and hydroxylation in vitro. https://app.cochat.ai/papers/10.1111/j.1365-2125.2004.02156.x
- The paper
- Ward, B. A., Morocho, A., Kandil, A., Galinsky, R. E., Flockhart, D. A., & Desta, Z. (2004). Characterization of human cytochrome P450 enzymes catalyzing domperidone N‐dealkylation and hydroxylation in vitro. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2004.02156.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.